Cross Border, Cost Effective Solutions
HIRO offers a unique combination of local expertise and international mindset to deliver cross border, cost effective solutions. With its headquarters in Shanghai and global footprints across Asia-Pacific, US and Europe, HIRO is well positioned to support biotech and pharma looking to conduct global clinical trials.
Lab-to-patient
HiRO delivers accelerated commercialisation pathways to global biotech and pharma. Recognising the need to simplify and accelerate trials, our unique lab-to-patient model strives to offer a more comprehensive range of solutions to better support biotech’s through their entire product journey.
Global Model
Looking to reduce development timelines, our global model is simple;
- through PharmaSols, leverage the benefits of the AU NZ region for early stage clinical trials to maximise the regions streamlined regulatory pathways and cost-effective start-up timeframes.
- leverage HiROs global reach to provide global support for later phase clinical trials where greater participant populations are required.
How We Deliver
We Are Experts
Your Go-To Region
Creative Solutions
Rapid Start Up
Global Solutions